If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerrexpo Regulatory News (FXPO)

  • This share is currently suspended. It was suspended at a price of 28.58

Share Price Information for Ferrexpo (FXPO)

Share Price is delayed by 15 minutes
Get Live Data
28.58    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £168.16m
FXPO Live PriceLast checked at - London Stock Exchange

Intraday Ferrexpo Share Chart

Production Report for 2Q 2021

7 Jul 2021 07:00

RNS Number : 4224E
Ferrexpo PLC
07 July 2021
 

 

 

7 July 2021

Ferrexpo plc

("Ferrexpo" or the "Company" or the "Group")

 

Production Report for 2Q 2021

 

Summary:

· COVID-19 update: Ferrexpo's operations and logistics continued to operate with minimal impact during 2Q 2021.

· Total iron ore pellet production of 2.8 million tonnes ("Mt") in 2Q 2021, representing a 5% increase quarter on quarter and in line year on year (-0.8%), with quarterly growth reflecting the successful completion of pelletiser upgrade work during the prior period.

o Upgrade work on the third pellet line, out of four pellet lines overall, completed at the end of June 2021.

o A final pelletiser line upgrade is planned for 3Q 2021, with the Group's overall pelletiser capacity to increase by 0.5-1.0Mt per annum following completion of this work.

· Production of high-quality pellets (65% Fe and 67% Fe) represented 100% of total pellet output in 2Q 2021 (2Q 2020: 99%).

· The Group continues to develop its offering of direct reduction ("DR") 67% Fe pellets, with this pellet type representing the pathway to low-carbon steel production. In the first half of 2021, the Group signed its first long term contract for the supply of DR pellets, with further trial shipments and samples for testing dispatched to additional prospective customers.

· Additional production of 85,000 tonnes of high-grade concentrate for sale in 2Q 2021, relating to the commissioning and ramp up of the Group's concentrate stockyard project, an investment that enables the continued production of concentrate during periods of pelletiser maintenance and upgrade work.

· Total sales volumes of 5.6Mt in 1H 2021, broadly in line with production for the period, and a 9% reduction year on year as a result of the stockpile drawdown process carried out in 1H 2020.

 

(000' tonnes, unless stated otherwise)

Product Grade

2Q2021

vs 1Q 2021

vs 2Q 2020

6M2021

vs 6M2020

Total commercial production(comprising pellets & concentrate)

2,934

+6%

+2%

5,712

+2%

Pellet production

 

2,849

+5%

(0.8%)

5,563

(0.6%)

Pellet production comprised of:

 

o Direct Reduction ("DR") Pellets*

67% Fe

85

+70%

(13%)

135

(28%)

o Ferrexpo Premium Pellets

65% Fe

2,764

+4%

+0.5%

5,428

+2%

o Ferrexpo Basic Pellets

62% Fe

-

-

(100%)

-

(100%)

Commercial concentrate production

67% Fe

85

+31%

-

149

-

Note: all production shown in table above from own ore; no production from third party materials.

* Please note that the above figure for DR pellet production in 1Q 2021 has been adjusted to reflect an additional 14kt of production in 1Q 2021, with production of 65% Fe production adjusted down by the corresponding amount. The total volume of pellet production remains unchanged for this period.

 

For further information, please contact:

 

Ferrexpo:

Rob Simmons

r.simmons@ferrexpo.ch

+44 207 389 8305

Tavistock:

Jos Simson

Gareth Tredway

Annabel de Morgan

ferrexpo@tavistock.co.uk

+44 207 920 3150

+44 778 855 4035

 

Notes to Editors:

Ferrexpo is a Swiss headquartered iron ore company with assets in Ukraine. It has been mining, processing and selling high quality iron ore pellets to the global steel industry for over 40 years. In 2020, the Group produced 11.2 Mt of iron ore pellets, a 7% increase on the prior year. The Company is ranked as the world's 3rd largest exporter of pellets to the global steel industry with a market share of approximately 9%. Ferrexpo has a diversified customer base supplying steel mills in Austria, Germany, Japan, South Korea, Taiwan, China, Slovakia, the Czech Republic, Turkey, Vietnam and America. Ferrexpo has a premium listing on the main market of the London Stock Exchange under the ticker FXPO. For further information, please visit www.ferrexpo.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUBAVRAWUBRRR
Date   Source Headline
1st Jul 202612:48 pmRNSReport on Payments to Governments to 31 Dec 2025
29th Jun 20266:00 pmRNSSuspended Company Notice - Deletion
29th Jun 20261:09 pmRNSResults of Annual General Meeting
29th Jun 20267:00 amRNSAGM Statement
29th May 20267:00 amRNSNotice of 2026 Annual General Meeting
28th Apr 20267:00 amRNSFunding Update and Delay in Financial Statements
22nd Apr 20267:00 amRNSUpdate on funding options
20th Apr 20267:00 amRNSSale of Iron Destiny and Update on Funding Options
15th Apr 20267:00 amRNSProduction Report for 1Q 2026
1st Apr 20269:41 amRNSTrading Update
9th Mar 20267:00 amRNSOperations and Corporate Update
2nd Mar 20268:20 amRNSDirector/PDMR Shareholding
24th Feb 20263:35 pmRNSUpdate regarding Ukrainian subsidiary
20th Jan 20263:39 pmRNSUpdate on operations in Ukraine
14th Jan 20267:00 amRNSProduction Report for 4Q 2025
31st Dec 20257:00 amRNS-REnd of year letter from Interim Executive Chair
31st Dec 20257:00 amRNS-REnd of year letter from Interim Executive Chair
14th Nov 20257:05 amRNSDirector Declaration
10th Nov 20257:00 amRNSLimited attack on power infrastructure
4th Nov 20257:00 amRNSPublication of Responsible Business Report
6th Oct 20257:00 amRNSProduction Report for 3Q 2025
11th Sep 202511:59 amRNSGeneral Meeting voting results
11th Aug 20257:00 amRNSPublication of Notice of General Meeting 2025
6th Aug 20257:00 amRNSInterim Results for six months ended 30 June 2025
7th Jul 20257:00 amRNSProduction Report for 2Q 2025
10th Jun 20254:48 pmRNSDirector/PDMR Shareholding
9th Jun 20254:35 pmRNSDirector/PDMR Shareholding
22nd May 202512:47 pmRNSResult of AGM
16th May 20255:00 pmRNSReport on Payments to Governments
15th May 202512:15 pmRNSUpdate regarding Ukrainian subsidiary
30th Apr 20257:00 amRNSLetter to shareholders re: auditor engagement
17th Apr 20255:32 pmRNSUkraine subsidiaries VAT refunds
10th Apr 20257:00 amRNSNotice of Annual General Meeting and 2024 ARA
7th Apr 20257:00 amRNSProduction Report for 1Q 2025
21st Mar 20257:00 amRNSStatement regarding Ukraine VAT refunds
19th Mar 20258:00 amRNSInternational Investment Agreements Notification
19th Mar 20257:00 amRNSFull Year Financial Results for 2024
11th Mar 20257:00 amRNSAnnouncement of Full Year 2024 Financial Results
5th Mar 20257:00 amRNSResponse to SBI Statement
4th Feb 20253:17 pmRNSUpdate regarding Ukrainian subsidiary
23rd Jan 20259:52 amRNSUpdate regarding Ukrainian Subsidiary
16th Jan 202511:30 amRNSUpdate regarding Ukrainian subsidiary
13th Jan 20257:00 amRNSResignation of Non-Executive Director
9th Jan 20257:00 amRNSProduction Report for 4Q 2024
30th Dec 20245:00 pmRNSPublication of Climate Change Report
30th Dec 20245:00 pmRNSPublication of Responsible Business Report
7th Oct 20247:00 amRNSProduction Report for 3Q 2024
19th Sep 202412:31 pmRNSGeneral Meeting voting results
12th Aug 20247:00 amRNSNotice of General Meeting 2024
5th Aug 20244:50 pmRNSUpdate on restrictions on shares in subsidiary

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.